What does DR. VERMEIREN - DR. THIBAUT do?

DR. VERMEIREN - DR. THIBAUT is a specialist medical practice in Mortsel. Private Limited, started on 29 January 2008.

What is the address of DR. VERMEIREN - DR. THIBAUT?

The registered office of DR. VERMEIREN - DR. THIBAUT is located at Liersesteenweg 318, 2640 Mortsel.

Is DR. VERMEIREN - DR. THIBAUT still active?

Yes. According to the CBE (17 September 2026) DR. VERMEIREN - DR. THIBAUT is active, legal situation “Normale toestand”, started on 29 January 2008.

Is DR. VERMEIREN - DR. THIBAUT registered on Peppol?

Yes, DR. VERMEIREN - DR. THIBAUT is registered on the Peppol network with ID 0208:0895393736.

What is the enterprise number of DR. VERMEIREN - DR. THIBAUT?

The enterprise number of DR. VERMEIREN - DR. THIBAUT is BE0895393736.

When was DR. VERMEIREN - DR. THIBAUT founded?

DR. VERMEIREN - DR. THIBAUT was founded on 29 January 2008.

Who are the directors of DR. VERMEIREN - DR. THIBAUT?

According to the 2024 annual accounts, the directors of DR. VERMEIREN - DR. THIBAUT are: KRISTIN THIBAUT, JAN VERMEIREN.

Is DR. VERMEIREN - DR. THIBAUT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 January 2008; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did DR. VERMEIREN - DR. THIBAUT make in 2024?

DR. VERMEIREN - DR. THIBAUT posted a profit after taxes of € 31,013 in financial year 2024.

What is the revenue of DR. VERMEIREN - DR. THIBAUT?

As a small company, DR. VERMEIREN - DR. THIBAUT is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 35,000.

DR. VERMEIREN - DR. THIBAUT (Private Limited) - Mortsel

Dossier DR. VERMEIREN - DR. THIBAUT, printed on 17 September 2026 from databakkes.be/en/0895393736/dr-vermeiren-dr-thibaut. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DR. VERMEIREN - DR. THIBAUT from Mortsel, company number BE0895393736, closed financial year 2024 with a result of € 31,013 after tax. For that financial year DR. VERMEIREN - DR. THIBAUT recorded a gross margin of € 35,000 and equity of € 599,564. Compared with financial year 2023, the result moved from € -24,736 to € 31,013. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2025.

What it is worth Healthy

€ 599,564

▼ 13% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 31,013

▲ still € 24,736 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 57,008

▲ 36% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 119,535 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 1,955

▲ 61% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,588

▲ € 4,112 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,969

▼ 12% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 221,445 Gross margin 2021: € 221,445 First fiscal year in the series	€ 190,115 Gross margin 2022: € 190,115 ▼ 14% vs 2021 (€ 221,445) Unfavourable step	€ 9,687 Gross margin 2023: € 9,687 ▼ 95% vs 2022 (€ 190,115) Unfavourable step	€ 35,000 Gross margin 2024: € 35,000 ▲ 261% vs 2023 (€ 9,687) Favourable step	▲ 261%
Profit after taxes	€ 127,646 Profit after taxes 2021: € 127,646 First fiscal year in the series	€ 125,230 Profit after taxes 2022: € 125,230 ▼ 2% vs 2021 (€ 127,646) Unfavourable step	€ -24,736 Profit after taxes 2023: € -24,736 ▼ € 149,966 vs 2022 (€ 125,230) Unfavourable step	€ 31,013 Profit after taxes 2024: € 31,013 ▲ € 55,749 vs 2023 (€ -24,736) Favourable step	▲ € 55,749
Equity	€ 830,510 Equity 2021: € 830,510 First fiscal year in the series	€ 788,454 Equity 2022: € 788,454 ▼ 5% vs 2021 (€ 830,510) Unfavourable step	€ 688,087 Equity 2023: € 688,087 ▼ 13% vs 2022 (€ 788,454) Unfavourable step	€ 599,564 Equity 2024: € 599,564 ▼ 13% vs 2023 (€ 688,087) Unfavourable step	▼ 13%
Total debts	€ 35,453 Total debts 2021: € 35,453 First fiscal year in the series	€ 63,978 Total debts 2022: € 63,978 ▲ 80% vs 2021 (€ 35,453) Unfavourable step	€ 11,963 Total debts 2023: € 11,963 ▼ 81% vs 2022 (€ 63,978) Favourable step	€ 8,656 Total debts 2024: € 8,656 ▼ 28% vs 2023 (€ 11,963) Favourable step	▼ 28%
Cash	€ 427,413 Cash 2021: € 427,413 First fiscal year in the series	€ 533,914 Cash 2022: € 533,914 ▲ 25% vs 2021 (€ 427,413) Favourable step	€ 41,822 Cash 2023: € 41,822 ▼ 92% vs 2022 (€ 533,914) Unfavourable step	€ 57,008 Cash 2024: € 57,008 ▲ 36% vs 2023 (€ 41,822) Favourable step	▲ 36%
Retained profit	€ 824,310 Retained profit 2021: € 824,310 First fiscal year in the series	€ 782,254 Retained profit 2022: € 782,254 ▼ 5% vs 2021 (€ 824,310) Unfavourable step	€ 681,887 Retained profit 2023: € 681,887 ▼ 13% vs 2022 (€ 782,254) Unfavourable step	€ 593,364 Retained profit 2024: € 593,364 ▼ 13% vs 2023 (€ 681,887) Unfavourable step	▼ 13%
Dividend	€ 204,047 Dividend 2021: € 204,047 First fiscal year in the series	€ 167,286 Dividend 2022: € 167,286 ▼ 18% vs 2021 (€ 204,047) Unchanged	€ 75,631 Dividend 2023: € 75,631 ▼ 55% vs 2022 (€ 167,286) Unchanged	€ 119,535 Dividend 2024: € 119,535 ▲ 58% vs 2023 (€ 75,631) Unchanged	▲ 58%
Balance sheet total	€ 865,963 Balance sheet total 2021: € 865,963 First fiscal year in the series	€ 852,432 Balance sheet total 2022: € 852,432 ▼ 2% vs 2021 (€ 865,963) Unchanged	€ 700,050 Balance sheet total 2023: € 700,050 ▼ 18% vs 2022 (€ 852,432) Unchanged	€ 608,220 Balance sheet total 2024: € 608,220 ▼ 13% vs 2023 (€ 700,050) Unchanged	▼ 13%

Key figures of DR. VERMEIREN - DR. THIBAUT, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR. VERMEIREN - DR. THIBAUT?

What happened at DR. VERMEIREN - DR. THIBAUT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 22, 2025 New annual accounts for financial year 2024: profit of € 31,013. filed late Source: NBB ↗
Jan 29, 2008 Start of the company according to the CBE. KBO

In short

From € 127,646 profit in 2021 to € 31,013 profit in 2024.

Paid € 147,821 in corporate taxes since 2021.

Best year ever: 2021, with € 127,646 profit.

Paid out € 566,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VERMEIREN - DR. THIBAUT? We notify you, reason included.

Follow DR. VERMEIREN - DR. THIBAUT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

KRISTIN THIBAUT JAN VERMEIREN

DR. VERMEIREN - DR. THIBAUT

Behind DR. VERMEIREN - DR. THIBAUT are KRISTIN THIBAUT and JAN VERMEIREN.

See the full network in the app

Directors

According to the 2024 annual accounts

KRISTIN THIBAUT

Director

JAN VERMEIREN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Liersesteenweg 318

2640 Mortsel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Shinrin

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0895.393.736

VAT number

BE 0895.393.736

Registered office

Liersesteenweg 318, 2640 Mortsel

Names & denominations

DR. VERMEIREN - DR. THIBAUT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 January 2008

Peppol

Active · Active since 27 Mar 2026

Activities · NACE

Activiteiten van medisch specialisten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige vormen van onderwijs

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. VERMEIREN - DR. THIBAUT

Financials

What happened to DR. VERMEIREN - DR. THIBAUT?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions